Aurobindo Pharma submits press release

14 Apr 2025 Evaluate

Aurobindo Pharma has submitted a press release on receipt of final ANDA approval for RivaroxavanTablets USP.

The above information is a part of company’s filings submitted to BSE.


Aurobindo Pharma Share Price

1194.90 -11.05 (-0.92%)
29-Dec-2025 14:12 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1716.00
Dr. Reddys Lab 1266.30
Cipla 1496.65
Zydus Lifesciences 906.20
Lupin 2084.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×